Income before deduction of interest, taxes and amortization: NeuroBo Pharmaceuticals, Inc. (NRBO)
The market awaits the publication of interim trial results for MASH and obesity drugs, with support from corporate behemoths already priced in. However, NeuroBo Pharmaceuticals (NRBO) faces clinical test uncertainty and funding risks. The EBITDA volume, which forms this chart via GURU.Markets data, has reached . High patent scalability allows for the minimization of costs during the industrial production of medications.
NeuroBo Pharmaceuticals, Inc. - analytical breakdowns and key metrics (NRBO)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Debt to Capital NeuroBo Pharmaceuticals|NRBO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital NeuroBo Pharmaceuticals Inc|NRBO - Company Debts|Debts to Book Capitalization Ratio NeuroBo Pharmaceuticals|NRBO - Company Long-Term Debts|Company Short-Term Loans and Borrowings NeuroBo Pharmaceuticals|Quick Ratio neurobopharma.com
- earnings and market multiples details:
NRBO - Company Net Income|Expected Net Income NeuroBo Pharmaceuticals|NRBO - Price to Earnings Ratio|Projected Price to Earnings neurobopharma.com|NRBO - PEG Multiple|EV/EBITDA Multiple NeuroBo Pharmaceuticals|NRBO - Operating profit EBITDA|Net earnings per share for the last 12 months NeuroBo Pharmaceuticals|NRBO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months neurobopharma.com|NRBO - Net earnings per share growth this year|Earnings growth forecast for next year NeuroBo Pharmaceuticals
- sales revenue and business income indicators:
Analysis of all company metrics:NeuroBo Pharma, NRBO
The specific nature of NeuroBo Pharmaceuticals (NRBO), which focuses on clinical trials for metabolic pathologies, results in a lack of proprietary revenue and a dependence on external financing. By analyzing the EBITDA level, an investor assesses the real cash flow stripped of non-cash accounting adjustments, which in this case confirms the business's investment development stage and a lack of operational self-sufficiency.
Who NeuroBo Pharmaceuticals competes with
Operating profit EBITDA Biogen Idec BIIB|NBIX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RGC (regencellbioscience.com)|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|CPRX - Profit before interest, taxes and amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization AMLX|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|OMER - Operating profit before deduction of amortization|Neurogene - Operating profit EBITDA|ACIU - Operating profit EBITDA|VYGR: Operating profit EBITDA|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating profit EBITDA Cognition Therapeutics Inc. (CGTX)|Inhibikase - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAVA (Cassava Pharma)|Assertio Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|VTGN: Operating profit EBITDA|Operating profit before deduction of amortization Ovid Therapeutics|ABOS (Acumen Pharma) - Operating profit EBITDA|Operating profit EBITDA CervoMed Corporation|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Profit before payment of interest, taxes and amortization CLNN (clene.com)|Profit before payment of interest, taxes and amortization PepGen PEPG|Operating income before deduction of amortization Jupiter Neurosciences, Inc. (JUNS)|RLMD - Profit before payment of interest, taxes and amortization|ANVS (Annovis Bio Corporation) - Operating profit before amortization|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|fireflyneuro.com - Income before deduction of interest, taxes and amortization|KLTO (ANEW Medical) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NRSN|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|HSDT: Operating profit before amortization|Passage Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences Corp) - Operating profit before deduction of amortization|Athira Pharma Corp (ATHA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Addex Therapeutics|ALZN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|PTIX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Pasithea Therapeutics Corp. KTTA|CRGT: Operating profit before amortization|Avenue Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization brainstorm-cell.com|CARA (Cara Therapeutics) - Operating profit before deduction of amortization|Chromocell Therapeutics Corp (CHRO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Eliem Therapeutics, Inc.|ITCI: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Longboard Pharmaceuticals (LBPH)|MRNS - Profit before interest, taxes and amortization|Operating profit EBITDA NKGN (NKGen Biotech)|Sage Therapeutics Inc. - Profit before payment of interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
